Short Interest in CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Rises By 19.3%

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 20,400 shares, an increase of 19.3% from the September 30th total of 17,100 shares. Based on an average daily trading volume, of 31,700 shares, the days-to-cover ratio is currently 0.6 days.

CERo Therapeutics Stock Performance

CEROW remained flat at $0.01 on Tuesday. 11,530 shares of the company’s stock were exchanged, compared to its average volume of 44,700. The company has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.03. CERo Therapeutics has a one year low of $0.00 and a one year high of $0.25.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.